Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of a recombinant RSV vaccine (CHO cells) in adults aged 60 years and older
CTR20254093Phase 2Active
- Sponsor
- Painuo Bio
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant respiratory syncytial virus vaccine in respiratory syncytial virus lower respiratory tract infection, sponsored by Painuo Bio. Started Oct 2025; status: active.
02
Drugs
recombinant respiratory syncytial virus vaccine
03
Conditions
respiratory syncytial virus lower respiratory tract infection
Beyond the preview
Go deeper on CTR20254093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254093.